Locations
Northbrook, IL, USA · West Lafayette, IN, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series C+
founded in
2010
On Target Laboratories is a biotechnology start-up focused on developing targeted intraoperative molecular imaging agents that help surgeons detect and remove cancerous tissues more effectively during surgery. Their flagship product, Cytalux, is FDA-approved for use in ovarian and lung cancer, enhancing surgical outcomes by illuminating cancerous lesions in real-time. Founded in 2010, the company leverages pioneering research from Purdue University to advance cancer imaging technology, aiming to improve patient outcomes and reduce the likelihood of residual cancer post-surgery. With a commitment to innovation and compassion, On Target Laboratories is positioned to make significant impacts in the oncology field.
Is this your company?
Something looks off?